Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Influenza

Free Subscription Articles published in Virology Retrieve available abstracts of 178 articles: HTML format

Single Articles

June 2021
1. TERRY JS, Anderson LB, Scherman MS, McAlister CE, et al
   Development of a SARS-CoV-2 nucleocapsid specific monoclonal antibody.
   Virology. 2021;558:28-37.
   PubMed     Abstract available
   
   
   
2. NAYAK K, Gottimukkala K, Kumar S, Reddy ES, et al
   Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India.
   Virology. 2021;558:13-21.
   PubMed     Abstract available
   
   
   May 2021
3. CASE JB, Winkler ES, Errico JM, Diamond MS, et al
   On the road to ending the COVID-19 pandemic: Are we there yet?
   Virology. 2021;557:70-85.
   PubMed     Abstract available
   
   
   
4. DJUKIC T, Mladenovic M, Stanic-Vucinic D, Radosavljevic J, et al
   Expression, purification and immunological characterization of recombinant nucleocapsid protein fragment from SARS-CoV-2.
   Virology. 2021;557:15-22.
   PubMed     Abstract available
   
   
   April 2021
5. UPRETY T, Sreenivasan CC, Bhattarai S, Wang D, et al
   Isolation and development of bovine primary respiratory cells as model to study influenza D virus infection.
   Virology. 2021;559:89-99.
   PubMed     Abstract available
   
   
   
6. WATERS K, Wan HJ, Han L, Xue J, et al
   Variations outside the conserved motifs of PB1 catalytic active site may affect replication efficiency of the RNP complex of influenza A virus.
   Virology. 2021;559:145-155.
   PubMed     Abstract available
   
   
   
7. NOLAN KE, Baer LA, Karekar P, Nelson AM, et al
   Metabolic shifts modulate lung injury caused by infection with H1N1 influenza A virus.
   Virology. 2021;559:111-119.
   PubMed     Abstract available
   
   
   
8. STAUFT CB, Lien CZ, Selvaraj P, Liu S, et al
   The G614 pandemic SARS-CoV-2 variant is not more pathogenic than the original D614 form in adult Syrian hamsters.
   Virology. 2021;556:96-100.
   PubMed     Abstract available
   
   
   
9. DETSIKA MG, Ampelakiotou K, Grigoriou E, Psarra K, et al
   A novel ratio of CD8(+):B-cells as a prognostic marker of coronavirus disease 2019 patient progression and outcome.
   Virology. 2021;556:79-86.
   PubMed     Abstract available
   
   
   
10. ZHIRNOV OP, Chlanda P
    The cleavage of spike protein capital EN, Cyrilliccapital A, Cyrillic0-->capital EN, Cyrilliccapital A, Cyrillic1/HA2 by trypsin permits activation of the M2 channel without its proteolytic cleavage in the influenza A virus.
    Virology. 2021;559:86-88.
    PubMed     Abstract available
    
    
    March 2021
11. SEEKINGS AH, Warren CJ, Thomas SS, Mahmood S, et al
    Highly pathogenic avian influenza virus H5N6 (clade 2.3.4.4b) has a preferable host tropism for waterfowl reflected in its inefficient transmission to terrestrial poultry.
    Virology. 2021;559:74-85.
    PubMed     Abstract available
    
    
    
12. WOLF JJ, Xia C, Studstill CJ, Ngo H, et al
    Influenza A virus NS1 induces degradation of sphingosine 1-phosphate lyase to obstruct the host innate immune response.
    Virology. 2021;558:67-75.
    PubMed     Abstract available
    
    
    
13. XIE L, Yi K, Li Y
    SARS_CoV2 RBD gene transcription cannot be driven by CMV promoter.
    Virology. 2021;558:22-27.
    PubMed     Abstract available
    
    
    
14. LU KT, Yamamoto T, McDonald D, Li W, et al
    U.S.-Japan cooperative medical sciences program: 22nd International Conference on Emerging Infectious Diseases in the Pacific Rim.
    Virology. 2021;555:71-77.
    PubMed     Abstract available
    
    
    
15. TAKESHITA M, Nishina N, Moriyama S, Takahashi Y, et al
    Incomplete humoral response including neutralizing antibodies in asymptomatic to mild COVID-19 patients in Japan.
    Virology. 2021;555:35-43.
    PubMed     Abstract available
    
    
    February 2021
16. NOMURA N, Matsuno K, Shingai M, Ohno M, et al
    Updating the influenza virus library at Hokkaido University -It's potential for the use of pandemic vaccine strain candidates and diagnosis.
    Virology. 2021;557:55-61.
    PubMed     Abstract available
    
    
    
17. ABDEL-MONEIM AS, Abdelwhab EM, Memish ZA
    Insights into SARS-CoV-2 evolution, potential antivirals, and vaccines.
    Virology. 2021;558:1-12.
    PubMed     Abstract available
    
    
    
18. ISHIGAKI H, Nakayama M, Kitagawa Y, Nguyen CT, et al
    Neutralizing antibody-dependent and -independent immune responses against SARS-CoV-2 in cynomolgus macaques.
    Virology. 2021;554:97-105.
    PubMed     Abstract available
    
    
    
19. REFAEY RH, El-Ashrey MK, Nissan YM
    Repurposing of renin inhibitors as SARS-COV-2 main protease inhibitors: A computational study.
    Virology. 2021;554:48-54.
    PubMed     Abstract available
    
    
    January 2021
20. FREIRE-PASPUEL B, Vega-Marino P, Velez A, Cruz M, et al
    Analytical and clinical comparison of Viasure (CerTest Biotec) and 2019-nCoV CDC (IDT) RT-qPCR kits for SARS-CoV2 diagnosis.
    Virology. 2021;553:154-156.
    PubMed     Abstract available
    
    
    December 2020
21. MORE SA, Patil AS, Sakle NS, Mokale SN, et al
    Network analysis and molecular mapping for SARS-CoV-2 to reveal drug targets and repurposing of clinically developed drugs.
    Virology. 2020;555:10-18.
    PubMed     Abstract available
    
    
    
22. LI L, Liang Y, Hu F, Yan H, et al
    Molecular and serological characterization of SARS-CoV-2 infection among COVID-19 patients.
    Virology. 2020;551:26-35.
    PubMed     Abstract available
    
    
    
23. JIANG RD, Li B, Liu XL, Liu MQ, et al
    Bat mammalian orthoreoviruses cause severe pneumonia in mice.
    Virology. 2020;551:84-92.
    PubMed     Abstract available
    
    
    November 2020
24. YU R, Tan S, Dan Y, Lu Y, et al
    Effect of SARS-CoV-2 coinfection was not apparent on the dynamics of chronic hepatitis B infection.
    Virology. 2020;553:131-134.
    PubMed     Abstract available
    
    
    
25. POWELL JD, Abente EJ, Chang J, Souza CK, et al
    Characterization of contemporary 2010.1 H3N2 swine influenza A viruses circulating in United States pigs.
    Virology. 2020;553:94-101.
    PubMed     Abstract available
    
    
    
26. JONES LR, Manrique JM
    Quantitative phylogenomic evidence reveals a spatially structured SARS-CoV-2 diversity.
    Virology. 2020;550:70-77.
    PubMed     Abstract available
    
    
    
27. DOBROVOLNY HM
    Quantifying the effect of remdesivir in rhesus macaques infected with SARS-CoV-2.
    Virology. 2020;550:61-69.
    PubMed     Abstract available
    
    
    
28. KISHKO M, Catalan J, Swanson K, DiNapoli J, et al
    Evaluation of the respiratory syncytial virus G-directed neutralizing antibody response in the human airway epithelial cell model.
    Virology. 2020;550:21-26.
    PubMed     Abstract available
    
    
    October 2020
29. WU T, Ge Y, Zhao K, Zhu X, et al
    A reverse-transcription recombinase-aided amplification assay for the rapid detection of N gene of severe acute respiratory syndrome coronavirus 2(SARS-CoV-2).
    Virology. 2020;549:1-4.
    PubMed     Abstract available
    
    
    September 2020
30. NISSLY RH, Zaman N, Ibrahim PAS, McDaniel K, et al
    Influenza C and D viral load in cattle correlates with bovine respiratory disease (BRD): Emerging role of orthomyxoviruses in the pathogenesis of BRD.
    Virology. 2020;551:10-15.
    PubMed     Abstract available
    
    
    
31. SEYED HOSSEINI E, Riahi Kashani N, Nikzad H, Azadbakht J, et al
    The novel coronavirus Disease-2019 (COVID-19): Mechanism of action, detection and recent therapeutic strategies.
    Virology. 2020;551:1-9.
    PubMed     Abstract available
    
    
    
32. MOHTADI N, Ghaysouri A, Shirazi S, Sara Ansari, et al
    Recovery of severely ill COVID-19 patients by intravenous immunoglobulin (IVIG) treatment: A case series.
    Virology. 2020;548:1-5.
    PubMed     Abstract available
    
    
    August 2020
33. KIM KH, Jung YJ, Lee Y, Park BR, et al
    Cross protection by inactivated recombinant influenza viruses containing chimeric hemagglutinin conjugates with a conserved neuraminidase or M2 ectodomain epitope.
    Virology. 2020;550:51-60.
    PubMed     Abstract available
    
    
    
34. ILYUSHINA NA, Lee N, Lugovtsev VY, Kan A, et al
    Adaptation of influenza B virus by serial passage in human airway epithelial cells.
    Virology. 2020;549:68-76.
    PubMed     Abstract available
    
    
    
35. NILSSON K, Abdurahman S, Schwartz S
    Influenza virus natural sequence heterogeneity in segment 8 affects interactions with cellular RNA-binding proteins and splicing efficiency.
    Virology. 2020;549:39-50.
    PubMed     Abstract available
    
    
    
36. JERRY C, Stallknecht D, Leyson C, Berghaus R, et al
    Recombinant hemagglutinin glycoproteins provide insight into binding to host cells by H5 influenza viruses in wild and domestic birds.
    Virology. 2020;550:8-20.
    PubMed     Abstract available
    
    
    
37. TANG J, Zhang SX, Zhang J, Li XY, et al
    Profile and generation of reduced neuraminidase inhibitor susceptibility in highly pathogenic avian influenza H7N9 virus from human cases in Mainland of China, 2016-2019.
    Virology. 2020;549:77-84.
    PubMed     Abstract available
    
    
    
38. MISHRA S, Goyal P, Kumar D, Chaudhari R, et al
    Experimental validation of influenza A virus matrix protein (M1) interaction with host cellular alpha enolase and pyruvate kinase.
    Virology. 2020;549:59-67.
    PubMed     Abstract available
    
    
    
39. ROTHAN HA, Stone S, Natekar J, Kumari P, et al
    The FDA-approved gold drug auranofin inhibits novel coronavirus (SARS-COV-2) replication and attenuates inflammation in human cells.
    Virology. 2020;547:7-11.
    PubMed     Abstract available
    
    
    July 2020
40. SHI F, Wu T, Zhu X, Ge Y, et al
    Association of viral load with serum biomakers among COVID-19 cases.
    Virology. 2020;546:122-126.
    PubMed     Abstract available
    
    
    June 2020
41. WOODS PS, Doolittle LM, Rosas LE, Nana-Sinkam SP, et al
    Increased expression of microRNA-155-5p by alveolar type II cells contributes to development of lethal ARDS in H1N1 influenza A virus-infected mice.
    Virology. 2020;545:40-52.
    PubMed     Abstract available
    
    
    March 2020
42. LIU R, Sreenivasan C, Yu H, Sheng Z, et al
    Influenza D virus diverges from its related influenza C virus in the recognition of 9-O-acetylated N-acetyl- or N-glycolyl-neuraminic acid-containing glycan receptors.
    Virology. 2020;545:16-23.
    PubMed     Abstract available
    
    
    February 2020
43. FANG QQ, Huang WJ, Li XY, Cheng YH, et al
    Effectiveness of favipiravir (T-705) against wild-type and oseltamivir-resistant influenza B virus in mice.
    Virology. 2020;545:1-9.
    PubMed     Abstract available
    
    
    
44. PURANIK A, Slomka MJ, Warren CJ, Thomas SS, et al
    Transmission dynamics between infected waterfowl and terrestrial poultry: Differences between the transmission and tropism of H5N8 highly pathogenic avian influenza virus (clade 2.3.4.4a) among ducks, chickens and turkeys.
    Virology. 2020;541:113-123.
    PubMed     Abstract available
    
    
    January 2020
45. MCALLISTER CS, Ansaldi D, Growcott EJ, Zhong Y, et al
    Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling.
    Virology. 2020;540:195-206.
    PubMed     Abstract available
    
    
    
46. LUDEKE B, Fearns R
    The respiratory syncytial virus polymerase can perform RNA synthesis with modified primers and nucleotide analogs.
    Virology. 2020;540:66-74.
    PubMed     Abstract available
    
    
    
47. ZOU S, Tang J, Zhang Y, Liu L, et al
    Molecular characterization of H3 subtype avian influenza viruses based on poultry-related environmental surveillance in China between 2014 and 2017.
    Virology. 2020;542:8-19.
    PubMed     Abstract available
    
    
    
48. STRAUS MR, Kinder JT, Segall M, Dutch RE, et al
    SPINT2 inhibits proteases involved in activation of both influenza viruses and metapneumoviruses.
    Virology. 2020;543:43-53.
    PubMed     Abstract available
    
    
    November 2019
49. LONDRIGAN SL, Wakim LM, Smith J, Haverkate AJ, et al
    IFITM3 and type I interferons are important for the control of influenza A virus replication in murine macrophages.
    Virology. 2019;540:17-22.
    PubMed     Abstract available
    
    
    
50. RODRIGUEZ P, Marcos-Villar L, Zamarreno N, Yanguez E, et al
    Mutations of the segment-specific nucleotides at the 3' end of influenza virus NS segment control viral replication.
    Virology. 2019;539:104-113.
    PubMed     Abstract available
    
    
    September 2019
51. YANG J, Xie D, Nie Z, Xu B, et al
    Inferring host roles in bayesian phylodynamics of global avian influenza A virus H9N2.
    Virology. 2019;538:86-96.
    PubMed     Abstract available
    
    
    
52. SHENG T, Sun Y, Sun J, Prinz RA, et al
    Role of TGF-beta-activated kinase 1 (TAK1) activation in H5N1 influenza A virus-induced c-Jun terminal kinase activation and virus replication.
    Virology. 2019;537:263-271.
    PubMed     Abstract available
    
    
    August 2019
53. ZHANG S, Huo C, Xiao J, Fan T, et al
    p-STAT1 regulates the influenza A virus replication and inflammatory response in vitro and vivo.
    Virology. 2019;537:110-120.
    PubMed     Abstract available
    
    
    
54. LEYSON C, Youk SS, Smith D, Dimitrov K, et al
    Pathogenicity and genomic changes of a 2016 European H5N8 highly pathogenic avian influenza virus (clade 2.3.4.4) in experimentally infected mallards and chickens.
    Virology. 2019;537:172-185.
    PubMed     Abstract available
    
    
    
55. PATEL H, Kukol A
    Prediction of ligands to universally conserved binding sites of the influenza a virus nuclear export protein.
    Virology. 2019;537:97-103.
    PubMed     Abstract available
    
    
    
56. PULIT-PENALOZA JA, Belser JA, Tumpey TM, Maines TR, et al
    Mammalian pathogenicity and transmissibility of a reassortant Eurasian avian-like A(H1N1v) influenza virus associated with human infection in China (2015).
    Virology. 2019;537:31-35.
    PubMed     Abstract available
    
    
    
57. TROST JF, Wang W, Liang B, Galloway SE, et al
    A conserved histidine in Group-1 influenza subtype hemagglutinin proteins is essential for membrane fusion activity.
    Virology. 2019;536:78-90.
    PubMed     Abstract available
    
    
    
58. GE Y, Chi Y, Min X, Zhao K, et al
    The evolution and characterization of influenza A(H7N9) virus under the selective pressure of peramivir.
    Virology. 2019;536:58-67.
    PubMed     Abstract available
    
    
    
59. DE VLUGT C, Sikora D, Rocheleau L, Pelchat M, et al
    Priming and realignment by the influenza a virus RdRp is dependent on the length of the host primers and the extent of base pairing to viral RNA.
    Virology. 2019;536:91-100.
    PubMed     Abstract available
    
    
    July 2019
60. SUN X, Belser JA, Yang H, Pulit-Penaloza JA, et al
    Identification of key hemagglutinin residues responsible for cleavage, acid stability, and virulence of fifth-wave highly pathogenic avian influenza A(H7N9) viruses.
    Virology. 2019;535:232-240.
    PubMed     Abstract available
    
    
    
61. HAO X, Wang X, Hu J, Gu M, et al
    The PB2 and M genes of genotype S H9N2 virus contribute to the enhanced fitness of H5Nx and H7N9 avian influenza viruses in chickens.
    Virology. 2019;535:218-226.
    PubMed     Abstract available
    
    
    
62. KIM KH, Lee YT, Park S, Jung YJ, et al
    Neuraminidase expressing virus-like particle vaccine provides effective cross protection against influenza virus.
    Virology. 2019;535:179-188.
    PubMed     Abstract available
    
    
    June 2019
63. XIAO Y, Park JK, Williams S, Ramuta M, et al
    Deep sequencing of 2009 influenza A/H1N1 virus isolated from volunteer human challenge study participants and natural infections.
    Virology. 2019;534:96-107.
    PubMed     Abstract available
    
    
    
64. NICHOLS JE, Niles JA, Fleming EH, Roberts NJ, et al
    The role of cell surface expression of influenza virus neuraminidase in induction of human lymphocyte apoptosis.
    Virology. 2019;534:80-86.
    PubMed     Abstract available
    
    
    
65. BERGMANN S, Elbahesh H
    Targeting the proviral host kinase, FAK, limits influenza a virus pathogenesis and NFkB-regulated pro-inflammatory responses.
    Virology. 2019;534:54-63.
    PubMed     Abstract available
    
    
    May 2019
66. YANG G, Chowdury S, Hodges E, Rahman MZ, et al
    Detection of highly pathogenic avian influenza A(H5N6) viruses in waterfowl in Bangladesh.
    Virology. 2019;534:36-44.
    PubMed     Abstract available
    
    
    
67. LEE Y, Ko EJ, Kim KH, Lee YT, et al
    A unique combination adjuvant modulates immune responses preventing vaccine-enhanced pulmonary histopathology after a single dose vaccination with fusion protein and challenge with respiratory syncytial virus.
    Virology. 2019;534:1-13.
    PubMed     Abstract available
    
    
    
68. OHTA K, Matsumoto Y, Nishio M
    Profilin2 is required for filamentous actin formation induced by human parainfluenza virus type 2.
    Virology. 2019;533:108-114.
    PubMed     Abstract available
    
    
    
69. MINE J, Uchida Y, Nakayama M, Tanikawa T, et al
    Genetics and pathogenicity of H5N6 highly pathogenic avian influenza viruses isolated from wild birds and a chicken in Japan during winter 2017-2018.
    Virology. 2019;533:1-11.
    PubMed     Abstract available
    
    
    April 2019
70. TRIGUEIRO-LOURO JM, Correia V, Santos LA, Guedes RC, et al
    To hit or not to hit: Large-scale sequence analysis and structure characterization of influenza A NS1 unlocks new antiviral target potential.
    Virology. 2019 Apr 27. pii: S0042-6822(19)30109.
    PubMed     Abstract available
    
    
    
71. MA J, Shen H, McDowell C, Liu Q, et al
    Virus survival and fitness when multiple genotypes and subtypes of influenza A viruses exist and circulate in swine.
    Virology. 2019;532:30-38.
    PubMed     Abstract available
    
    
    March 2019
72. TAKIZAWA N, Ogura Y, Fujita Y, Noda T, et al
    Local structural changes of the influenza A virus ribonucleoprotein complex by single mutations in the specific residues involved in efficient genome packaging.
    Virology. 2019;531:126-140.
    PubMed     Abstract available
    
    
    
73. YUMINE N, Matsumoto Y, Ohta K, Fukasawa M, et al
    Claudin-1 inhibits human parainfluenza virus type 2 dissemination.
    Virology. 2019;531:93-99.
    PubMed     Abstract available
    
    
    February 2019
74. REN L, Zhang W, Han P, Zhang J, et al
    Influenza A virus (H1N1) triggers a hypoxic response by stabilizing hypoxia-inducible factor-1alpha via inhibition of proteasome.
    Virology. 2019;530:51-58.
    PubMed     Abstract available
    
    
    
75. ZHANG T, Zhao H, Wang J, Han GZ, et al
    Wild birds do not harbor higher diversity of influenza virus internal genes than poultry.
    Virology. 2019;530:59-64.
    PubMed     Abstract available
    
    
    January 2019
76. SANADA T, Yasui F, Honda T, Kayesh MEH, et al
    Avian H5N1 influenza virus infection causes severe pneumonia in the Northern tree shrew (Tupaia belangeri).
    Virology. 2019;529:101-110.
    PubMed     Abstract available
    
    
    
77. LEE YT, Kim KH, Ko EJ, Kim MC, et al
    Enhancing the cross protective efficacy of live attenuated influenza virus vaccine by supplemented vaccination with M2 ectodomain virus-like particles.
    Virology. 2019;529:111-121.
    PubMed     Abstract available
    
    
    
78. KWON JH, Noh JY, Jeong JH, Jeong S, et al
    Different pathogenicity of two strains of clade 2.3.4.4c H5N6 highly pathogenic avian influenza viruses bearing different PA and NS gene in domestic ducks.
    Virology. 2019;530:11-18.
    PubMed     Abstract available
    
    
    
79. JESTER B, Uyeki TM, Jernigan DB, Tumpey TM, et al
    Historical and clinical aspects of the 1918 H1N1 pandemic in the United States.
    Virology. 2019;527:32-37.
    PubMed     Abstract available
    
    
    
80. SREENIVASAN CC, Thomas M, Antony L, Wormstadt T, et al
    Development and characterization of swine primary respiratory epithelial cells and their susceptibility to infection by four influenza virus types.
    Virology. 2019;528:152-163.
    PubMed     Abstract available
    
    
    
81. LIU L, Wang T, Wang M, Tong Q, et al
    Recombinant turkey herpesvirus expressing H9 hemagglutinin providing protection against H9N2 avian influenza.
    Virology. 2019;529:7-15.
    PubMed     Abstract available
    
    
    
82. ZOU S, Zhang Y, Li X, Bo H, et al
    Molecular characterization and receptor binding specificity of H9N2 avian influenza viruses based on poultry-related environmental surveillance in China between 2013 and 2016.
    Virology. 2019;529:135-143.
    PubMed     Abstract available
    
    
    
83. NIKOLAIDIS M, Mimouli K, Kyriakopoulou Z, Tsimpidis M, et al
    Large-scale genomic analysis reveals recurrent patterns of intertypic recombination in human enteroviruses.
    Virology. 2019;526:72-80.
    PubMed     Abstract available
    
    
    December 2018
84. MA LL, Zhang P, Wang HQ, Li YF, et al
    heme oxygenase-1 agonist CoPP suppresses influenza virus replication through IRF3-mediated generation of IFN-alpha/beta.
    Virology. 2018;528:80-88.
    PubMed     Abstract available
    
    
    
85. OHTSUKA J, Matsumoto Y, Ohta K, Fukumura M, et al
    Nucleocytoplasmic shuttling of the human parainfluenza virus type 2 phosphoprotein.
    Virology. 2018;528:54-63.
    PubMed     Abstract available
    
    
    November 2018
86. HIONO T, Matsuda A, Wagatsuma T, Okamatsu M, et al
    Lectin microarray analyses reveal host cell-specific glycan profiles of the hemagglutinins of influenza A viruses.
    Virology. 2018;527:132-140.
    PubMed     Abstract available
    
    
    
87. BELSER JA, Maines TR, Tumpey TM
    Importance of 1918 virus reconstruction to current assessments of pandemic risk.
    Virology. 2018;524:45-55.
    PubMed     Abstract available
    
    
    October 2018
88. NICOL MQ, Campbell GM, Shaw DJ, Dransfield I, et al
    Lack of IFNgamma signaling attenuates spread of influenza A virus in vivo and leads to reduced pathogenesis.
    Virology. 2018;526:155-164.
    PubMed     Abstract available
    
    
    
89. WANG SC, Liao HY, Zhang JY, Cheng TR, et al
    Development of a universal influenza vaccine using hemagglutinin stem protein produced from Pichia pastoris.
    Virology. 2018;526:125-137.
    PubMed     Abstract available
    
    
    
90. ZHANG J, Ruan T, Sheng T, Wang J, et al
    Role of c-Jun terminal kinase (JNK) activation in influenza A virus-induced autophagy and replication.
    Virology. 2018;526:1-12.
    PubMed     Abstract available
    
    
    
91. MARCHENKO V, Goncharova N, Susloparov I, Kolosova N, et al
    Isolation and characterization of H5Nx highly pathogenic avian influenza viruses of clade 2.3.4.4 in Russia.
    Virology. 2018;525:216-223.
    PubMed     Abstract available
    
    
    
92. NARKPUK J, Jongkaewwattana A, Teeravechyan S
    The avian influenza virus PA segment mediates strain-specific antagonism of BST-2/tetherin.
    Virology. 2018;525:161-169.
    PubMed     Abstract available
    
    
    
93. GONZALEZ-PARRA G, Dobrovolny HM
    A quantitative assessment of dynamical differences of RSV infections in vitro and in vivo.
    Virology. 2018;523:129-139.
    PubMed     Abstract available
    
    
    
94. MORGENE MF, Maurin C, Pillet S, Berthelot P, et al
    HaCaT epithelial cells as an innovative novel model of rhinovirus infection and impact of clarithromycin treatment on infection kinetics.
    Virology. 2018;523:27-34.
    PubMed     Abstract available
    
    
    September 2018
95. YAN LM, Li OTW, Poh CM, Perera RAPM, et al
    Combined use of live-attenuated and inactivated influenza vaccines to enhance heterosubtypic protection.
    Virology. 2018;525:73-82.
    PubMed     Abstract available
    
    
    
96. CUI L, Mahesutihan M, Zheng W, Meng L, et al
    CDC25B promotes influenza A virus replication by regulating the phosphorylation of nucleoprotein.
    Virology. 2018;525:40-47.
    PubMed     Abstract available
    
    
    
97. LI L, DeLiberto TJ, Killian ML, Torchetti MK, et al
    Evolutionary pathway for the 2017 emergence of a novel highly pathogenic avian influenza A(H7N9) virus among domestic poultry in Tennessee, United States.
    Virology. 2018;525:32-39.
    PubMed     Abstract available
    
    
    
98. XIAO Y, Nolting JM, Sheng ZM, Bristol T, et al
    Design and validation of a universal influenza virus enrichment probe set and its utility in deep sequence analysis of primary cloacal swab surveillance samples of wild birds.
    Virology. 2018;524:182-191.
    PubMed     Abstract available
    
    
    
99. KIM KH, Kwon YM, Lee YT, Hwang HS, et al
    Virus-like particles presenting flagellin exhibit unique adjuvant effects on eliciting T helper type 1 humoral and cellular immune responses to poor immunogenic influenza virus M2e protein vaccine.
    Virology. 2018;524:172-181.
    PubMed     Abstract available
    
    
    August 2018
100. OHTA K, Matsumoto Y, Yumine N, Nishio M, et al
     The V protein of human parainfluenza virus type 2 promotes RhoA-induced filamentous actin formation.
     Virology. 2018;524:90-96.
     PubMed     Abstract available
     
     
     
101. ZARUBAEV VV, Pushkina EA, Borisevich SS, Galochkina AV, et al
     Selection of influenza virus resistant to the novel camphor-based antiviral camphecene results in loss of pathogenicity.
     Virology. 2018;524:69-77.
     PubMed     Abstract available
     
     
     
102. SHIBATA A, Okamatsu M, Sumiyoshi R, Matsuno K, et al
     Repeated detection of H7N9 avian influenza viruses in raw poultry meat illegally brought to Japan by international flight passengers.
     Virology. 2018;524:10-17.
     PubMed     Abstract available
     
     
     July 2018
103. SUTTIE A, Karlsson EA, Deng YM, Horm SV, et al
     Influenza A(H5N1) viruses with A(H9N2) single gene (matrix or PB1) reassortment isolated from Cambodian live bird markets.
     Virology. 2018;523:22-26.
     PubMed     Abstract available
     
     
     
104. WANG Z, Huang B, Thomas M, Sreenivasan CC, et al
     Detailed mapping of the linear B Cell epitopes of the hemagglutinin (HA) protein of swine influenza virus.
     Virology. 2018;522:131-137.
     PubMed     Abstract available
     
     
     
105. CORREIA V, Abecasis AB, Rebelo-de-Andrade H
     Molecular footprints of selective pressure in the neuraminidase gene of currently circulating human influenza subtypes and lineages.
     Virology. 2018;522:122-130.
     PubMed     Abstract available
     
     
     
106. SHCHERBIK S, Carney P, Pearce N, Stevens J, et al
     Monoclonal antibody against N2 neuraminidase of cold adapted A/Leningrad/134/17/57 (H2N2) enables efficient generation of live attenuated influenza vaccines.
     Virology. 2018;522:65-72.
     PubMed     Abstract available
     
     
     
107. GAMBARYAN AS, Matrosovich TY, Boravleva EY, Lomakina NF, et al
     Receptor-binding properties of influenza viruses isolated from gulls.
     Virology. 2018;522:37-45.
     PubMed     Abstract available
     
     
     May 2018
108. LI Y, Sun L, Zheng W, Madina Mahesutihan, et al
     Phosphorylation and dephosphorylation of threonine 188 in nucleoprotein is crucial for the replication of influenza A virus.
     Virology. 2018;520:30-38.
     PubMed     Abstract available
     
     
     April 2018
109. LI J, Zhang K, Chen Q, Zhang X, et al
     Three amino acid substitutions in the NS1 protein change the virus replication of H5N1 influenza virus in human cells.
     Virology. 2018;519:64-73.
     PubMed     Abstract available
     
     
     March 2018
110. ISAKOVA-SIVAK I, Korenkov D, Smolonogina T, Kotomina T, et al
     Broadly protective anti-hemagglutinin stalk antibodies induced by live attenuated influenza vaccine expressing chimeric hemagglutinin.
     Virology. 2018;518:313-323.
     PubMed     Abstract available
     
     
     
111. CHRZASTEK K, Lee DH, Gharaibeh S, Zsak A, et al
     Characterization of H9N2 avian influenza viruses from the Middle East demonstrates heterogeneity at amino acid position 226 in the hemagglutinin and potential for transmission to mammals.
     Virology. 2018;518:195-201.
     PubMed     Abstract available
     
     
     February 2018
112. ZHANG S, Cheng Q, Luo C, Yin L, et al
     An alanine residue in human parainfluenza virus type 3 phosphoprotein is critical for restricting excessive N(0)-P interaction and maintaining N solubility.
     Virology. 2018;518:64-76.
     PubMed     Abstract available
     
     
     
113. RAMEY AM, DeLiberto TJ, Berhane Y, Swayne DE, et al
     Lessons learned from research and surveillance directed at highly pathogenic influenza A viruses in wild birds inhabiting North America.
     Virology. 2018;518:55-63.
     PubMed     Abstract available
     
     
     
114. RAJAO DS, Anderson TK, Kitikoon P, Stratton J, et al
     Antigenic and genetic evolution of contemporary swine H1 influenza viruses in the United States.
     Virology. 2018;518:45-54.
     PubMed     Abstract available
     
     
     January 2018
115. RODRIGUEZ L, Reedy S, Nogales A, Murcia PR, et al
     Development of a novel equine influenza virus live-attenuated vaccine.
     Virology. 2018;516:76-85.
     PubMed     Abstract available
     
     
     
116. OISHI K, Yamayoshi S, Kawaoka Y
     Identification of novel amino acid residues of influenza virus PA-X that are important for PA-X shutoff activity by using yeast.
     Virology. 2018;516:71-75.
     PubMed     Abstract available
     
     
     
117. LEE YN, Lee EK, Song BM, Heo GB, et al
     Evaluation of the zoonotic potential of multiple subgroups of clade 2.3.4.4 influenza A (H5N8) virus.
     Virology. 2018;516:38-45.
     PubMed     Abstract available
     
     
     December 2017
118. SUN H, Yao W, Wang K, Qian Y, et al
     Inhibition of neddylation pathway represses influenza virus replication and pro-inflammatory responses.
     Virology. 2017;514:230-239.
     PubMed     Abstract available
     
     
     
119. HERRERA-RODRIGUEZ J, Meijerhof T, Niesters HG, Stjernholm G, et al
     A novel peptide-based vaccine candidate with protective efficacy against influenza A in a mouse model.
     Virology. 2017;515:21-28.
     PubMed     Abstract available
     
     
     November 2017
120. AUMAYR M, Schrempf A, Uzulmez O, Olek KM, et al
     Interaction of 2A proteinase of human rhinovirus genetic group A with eIF4E is required for eIF4G cleavage during infection.
     Virology. 2017;511:123-134.
     PubMed     Abstract available
     
     
     October 2017
121. NI F, Kondrashkina E, Wang Q
     Determinant of receptor-preference switch in influenza hemagglutinin.
     Virology. 2017;513:98-107.
     PubMed     Abstract available
     
     
     
122. LION A, Richard M, Esnault E, Kut E, et al
     Productive replication of avian influenza viruses in chicken endothelial cells is determined by hemagglutinin cleavability and is related to innate immune escape.
     Virology. 2017;513:29-42.
     PubMed     Abstract available
     
     
     
123. LAU JW, Kim YI, Murphy R, Newman R, et al
     Deep sequencing of RSV from an adult challenge study and from naturally infected infants reveals heterogeneous diversification dynamics.
     Virology. 2017;510:289-296.
     PubMed     Abstract available
     
     
     
124. YE Z, Ren L, Tang Z, Deng Y, et al
     Pulmonary C-fiber degeneration downregulates IFN-gamma receptor 1 via IFN-alpha induction to attenuate RSV-induced airway hyperresponsiveness.
     Virology. 2017;510:262-272.
     PubMed     Abstract available
     
     
     September 2017
125. TAKEMAE N, Tsunekuni R, Sharshov K, Tanikawa T, et al
     Five distinct reassortants of H5N6 highly pathogenic avian influenza A viruses affected Japan during the winter of 2016-2017.
     Virology. 2017;512:8-20.
     PubMed     Abstract available
     
     
     
126. WILSON JR, Belser JA, DaSilva J, Guo Z, et al
     An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody protects mice from morbidity without interfering with the development of protective immunity to subsequent homologous challenge.
     Virology. 2017;511:214-221.
     PubMed     Abstract available
     
     
     August 2017
127. CHEN W, Xu Q, Zhong Y, Yu H, et al
     Genetic variation and co-evolutionary relationship of RNA polymerase complex segments in influenza A viruses.
     Virology. 2017;511:193-206.
     PubMed     Abstract available
     
     
     
128. NAGUIB MM, Arafa AS, Parvin R, Beer M, et al
     Insights into genetic diversity and biological propensities of potentially zoonotic avian influenza H9N2 viruses circulating in Egypt.
     Virology. 2017;511:165-174.
     PubMed     Abstract available
     
     
     
129. BELSER JA, Johnson A, Pulit-Penaloza JA, Pappas C, et al
     Pathogenicity testing of influenza candidate vaccine viruses in the ferret model.
     Virology. 2017;511:135-141.
     PubMed     Abstract available
     
     
     
130. HWANG HS, Lee YT, Kim KH, Ko EJ, et al
     Virus-like particle vaccine primes immune responses preventing inactivated-virus vaccine-enhanced disease against respiratory syncytial virus.
     Virology. 2017;511:142-151.
     PubMed     Abstract available
     
     
     
131. ABENTE EJ, Gauger PC, Walia RR, Rajao DS, et al
     Detection and characterization of an H4N6 avian-lineage influenza A virus in pigs in the Midwestern United States.
     Virology. 2017;511:56-65.
     PubMed     Abstract available
     
     
     
132. ROJO GL, Goya S, Orellana M, Sancilio A, et al
     Unravelling respiratory syncytial virus outbreaks in Buenos Aires, Argentina: Molecular basis of the spatio-temporal transmission.
     Virology. 2017;508:118-126.
     PubMed     Abstract available
     
     
     July 2017
133. NGUYEN LT, Nishi T, Shichinohe S, Chu DH, et al
     Selection of antigenic variants of an H5N1 highly pathogenic avian influenza virus in vaccinated chickens.
     Virology. 2017;510:252-261.
     PubMed     Abstract available
     
     
     
134. BAJIMAYA S, Frankl T, Hayashi T, Takimoto T, et al
     Cholesterol is required for stability and infectivity of influenza A and respiratory syncytial viruses.
     Virology. 2017;510:234-241.
     PubMed     Abstract available
     
     
     
135. ALKHERAIF AA, Topliff CL, Reddy J, Massilamany C, et al
     Type 2 BVDV Npro suppresses IFN-1 pathway signaling in bovine cells and augments BRSV replication.
     Virology. 2017;507:123-134.
     PubMed     Abstract available
     
     
     June 2017
136. SIKORA D, Rocheleau L, Brown EG, Pelchat M, et al
     Influenza A virus cap-snatches host RNAs based on their abundance early after infection.
     Virology. 2017;509:167-177.
     PubMed     Abstract available
     
     
     
137. CHLANDA P
     Influenza Hemagglutinin and M2 ion channel priming by trypsin: Killing two birds with one stone.
     Virology. 2017;509:131-132.
     PubMed     Abstract available
     
     
     
138. PATEL H, Kukol A
     Evolutionary conservation of influenza A PB2 sequences reveals potential target sites for small molecule inhibitors.
     Virology. 2017;509:112-120.
     PubMed     Abstract available
     
     
     
139. SMITH GE, Sun X, Bai Y, Liu YV, et al
     Neuraminidase-based recombinant virus-like particles protect against lethal avian influenza A(H5N1) virus infection in ferrets.
     Virology. 2017;509:90-97.
     PubMed     Abstract available
     
     
     
140. DENG L, Kim JR, Chang TZ, Zhang H, et al
     Protein nanoparticle vaccine based on flagellin carrier fused to influenza conserved epitopes confers full protection against influenza A virus challenge.
     Virology. 2017;509:82-89.
     PubMed     Abstract available
     
     
     May 2017
141. WANG BX, Brown EG, Fish EN
     Residues F103 and M106 within the influenza A virus NS1 CPSF4-binding region regulate interferon-stimulated gene translation initiation.
     Virology. 2017;508:170-179.
     PubMed     Abstract available
     
     
     
142. SUN X, Belser JA, Pulit-Penaloza JA, Creager HM, et al
     Stockpiled pre-pandemic H5N1 influenza virus vaccines with AS03 adjuvant provide cross-protection from H5N2 clade 2.3.4.4 virus challenge in ferrets.
     Virology. 2017;508:164-169.
     PubMed     Abstract available
     
     
     
143. LIN CY, Chia MY, Chen PL, Yeh CT, et al
     Assessment of pathogenicity and antigenicity of American lineage influenza H5N2 viruses in Taiwan.
     Virology. 2017;508:159-163.
     PubMed     Abstract available
     
     
     
144. XU G, Zhang X, Liu Q, Bing G, et al
     PA-X protein contributes to virulence of triple-reassortant H1N2 influenza virus by suppressing early immune responses in swine.
     Virology. 2017;508:45-53.
     PubMed     Abstract available
     
     
     April 2017
145. LEE DH, Torchetti MK, Killian ML, Swayne DE, et al
     Deep sequencing of H7N8 avian influenza viruses from surveillance zone supports H7N8 high pathogenicity avian influenza was limited to a single outbreak farm in Indiana during 2016.
     Virology. 2017;507:216-219.
     PubMed     Abstract available
     
     
     
146. CHUTIWITOONCHAI N, Mano T, Kakisaka M, Sato H, et al
     Inhibition of CRM1-mediated nuclear export of influenza A nucleoprotein and nuclear export protein as a novel target for antiviral drug development.
     Virology. 2017;507:32-39.
     PubMed     Abstract available
     
     
     
147. HILLYER P, Mane VP, Chen A, Dos Santos MB, et al
     Respiratory syncytial virus infection induces a subset of types I and III interferons in human dendritic cells.
     Virology. 2017;504:63-72.
     PubMed     Abstract available
     
     
     March 2017
148. NARKPUK J, Teeravechyan S, Puthavathana P, Jongkaewwattana A, et al
     Single nucleoprotein residue determines influenza A virus sensitivity to an intertypic suppression mechanism.
     Virology. 2017;506:99-109.
     PubMed     Abstract available
     
     
     
149. FOUGEROLLE S, Legrand L, Lecouturier F, Sailleau C, et al
     Genetic evolution of equine influenza virus strains (H3N8) isolated in France from 1967 to 2015 and the implications of several potential pathogenic factors.
     Virology. 2017;505:210-217.
     PubMed     Abstract available
     
     
     February 2017
150. CHEN LJ, Lin XD, Tian JH, Liao Y, et al
     Diversity, evolution and population dynamics of avian influenza viruses circulating in the live poultry markets in China.
     Virology. 2017;505:33-41.
     PubMed     Abstract available
     
     
     
151. CHAIMAYO C, Hayashi T, Underwood A, Hodges E, et al
     Selective incorporation of vRNP into influenza A virions determined by its specific interaction with M1 protein.
     Virology. 2017;505:23-32.
     PubMed     Abstract available
     
     
     
152. RODRIGUEZ L, Nogales A, Reilly EC, Topham DJ, et al
     A live-attenuated influenza vaccine for H3N2 canine influenza virus.
     Virology. 2017;504:96-106.
     PubMed     Abstract available
     
     
     January 2017
153. LEE YH, Jang YH, Seong BL
     Cell-cultured, live attenuated, X-31ca-based H5N1 pre-pandemic influenza vaccine.
     Virology. 2017;504:73-78.
     PubMed     Abstract available
     
     
     
154. PEETERS B, Reemers S, Dortmans J, de Vries E, et al
     Genetic versus antigenic differences among highly pathogenic H5N1 avian influenza A viruses: Consequences for vaccine strain selection.
     Virology. 2017;503:83-93.
     PubMed     Abstract available
     
     
     
155. RABBANI MA, Barik S
     5-Hydroxytryptophan, a major product of tryptophan degradation, is essential for optimal replication of human parainfluenza virus.
     Virology. 2017;503:46-51.
     PubMed     Abstract available
     
     
     
156. KIM SH, Paldurai A, Samal SK
     A novel chimeric Newcastle disease virus vectored vaccine against highly pathogenic avian influenza virus.
     Virology. 2017;503:31-36.
     PubMed     Abstract available
     
     
     December 2016
157. PEARCE MB, Pappas C, Gustin KM, Davis CT, et al
     Enhanced virulence of clade 2.3.2.1 highly pathogenic avian influenza A H5N1 viruses in ferrets.
     Virology. 2016;502:114-122.
     PubMed     Abstract available
     
     
     
158. SUPTAWIWAT O, Ninpan K, Boonarkart C, Ruangrung K, et al
     Evolutionary dynamic of antigenic residues on influenza B hemagglutinin.
     Virology. 2016;502:84-96.
     PubMed     Abstract available
     
     
     
159. BELSER JA, Sun X, Creager HM, Johnson A, et al
     Role of H7 hemagglutinin in murine infectivity of influenza viruses following ocular inoculation.
     Virology. 2016;502:13-19.
     PubMed     Abstract available
     
     
     
160. PUSHKO P, Tretyakova I, Hidajat R, Zsak A, et al
     Virus-like particles displaying H5, H7, H9 hemagglutinins and N1 neuraminidase elicit protective immunity to heterologous avian influenza viruses in chickens.
     Virology. 2016;501:176-182.
     PubMed     Abstract available
     
     
     
161. BAJIMAYA S, Hayashi T, Frankl T, Bryk P, et al
     Cholesterol reducing agents inhibit assembly of type I parainfluenza viruses.
     Virology. 2016;501:127-135.
     PubMed     Abstract available
     
     
     November 2016
162. HU M, Yuan S, Zhang K, Singh K, et al
     PB2 substitutions V598T/I increase the virulence of H7N9 influenza A virus in mammals.
     Virology. 2016;501:92-101.
     PubMed     Abstract available
     
     
     
163. LUO J, Ferguson L, Smith DR, Woolums AR, et al
     Serological evidence for high prevalence of Influenza D Viruses in Cattle, Nebraska, United States, 2003-2004.
     Virology. 2016;501:88-91.
     PubMed     Abstract available
     
     
     
164. ISAKOVA-SIVAK I, Korenkov D, Smolonogina T, Tretiak T, et al
     Comparative studies of infectivity, immunogenicity and cross-protective efficacy of live attenuated influenza vaccines containing nucleoprotein from cold-adapted or wild-type influenza virus in a mouse model.
     Virology. 2016;500:209-217.
     PubMed     Abstract available
     
     
     
165. KOSIK I, Yewdell JW
     Influenza A virus hemagglutinin specific antibodies interfere with virion neuraminidase activity via two distinct mechanisms.
     Virology. 2016;500:178-183.
     PubMed     Abstract available
     
     
     
166. GONZALEZ Y, Juarez E, Carranza C, Sada E, et al
     Diminished effector and memory CD8+ circulating T lymphocytes in patients with severe influenza caused by the AH1N1 pdm09 virus.
     Virology. 2016;500:139-148.
     PubMed     Abstract available
     
     
     
167. HARTWIG SM, Ketterer M, Apicella MA, Varga SM, et al
     Non-typeable Haemophilus influenzae protects human airway epithelial cells from a subsequent respiratory syncytial virus challenge.
     Virology. 2016;498:128-35.
     PubMed     Abstract available
     
     
     October 2016
168. GUJJAR N, Chothe SK, Gawai S, Nissly R, et al
     Co-expression of sialic acid receptors compatible with avian and human influenza virus binding in emus (Dromaius novaehollandiae).
     Virology. 2016;500:114-121.
     PubMed     Abstract available
     
     
     
169. CREAGER HM, Zeng H, Pulit-Penaloza JA, Maines TR, et al
     In vitro exposure system for study of aerosolized influenza virus.
     Virology. 2016;500:62-70.
     PubMed     Abstract available
     
     
     
170. NOGALES A, Huang K, Chauche C, DeDiego ML, et al
     Canine influenza viruses with modified NS1 proteins for the development of live-attenuated vaccines.
     Virology. 2016;500:1-10.
     PubMed     Abstract available
     
     
     
171. ELBAHESH H, Bergmann S, Russell CJ
     Focal adhesion kinase (FAK) regulates polymerase activity of multiple influenza A virus subtypes.
     Virology. 2016;499:369-374.
     PubMed     Abstract available
     
     
     
172. GARG R, Theaker M, Martinez EC, van Drunen Littel-van den Hurk S, et al
     A single intranasal immunization with a subunit vaccine formulation induces higher mucosal IgA production than live respiratory syncytial virus.
     Virology. 2016;499:288-297.
     PubMed     Abstract available
     
     
     
173. SHRIVASTAVA P, Sarkar I, Atanley E, Gomis S, et al
     IL-12p40 gene-deficient BALB/c mice exhibit lower weight loss, reduced lung pathology and decreased sensitization to allergen in response to infection with pneumonia virus of mice.
     Virology. 2016;497:1-10.
     PubMed     Abstract available
     
     
     September 2016
174. CUI P, Deng G, Shi J, Kong H, et al
     New influenza A(H7N7) viruses detected in live poultry markets in China.
     Virology. 2016;499:165-169.
     PubMed     Abstract available
     
     
     
175. DEJESUS E, Costa-Hurtado M, Smith D, Lee DH, et al
     Changes in adaptation of H5N2 highly pathogenic avian influenza H5 clade 2.3.4.4 viruses in chickens and mallards.
     Virology. 2016;499:52-64.
     PubMed     Abstract available
     
     
     
176. ISHIKAWA H, Fukui T, Ino S, Sasaki H, et al
     Influenza virus infection causes neutrophil dysfunction through reduced G-CSF production and an increased risk of secondary bacteria infection in the lung.
     Virology. 2016;499:23-29.
     PubMed     Abstract available
     
     
     
177. RAUFF D, Strydom C, Abolnik C
     Evolutionary consequences of a decade of vaccination against subtype H6N2 influenza.
     Virology. 2016;498:226-239.
     PubMed     Abstract available
     
     
     April 2016
178. HWANG HS, Lee YT, Kim KH, Park S, et al
     Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease.
     Virology. 2016;494:215-224.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: